Status:
COMPLETED
Sarcopenia and Short Bowel Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Sarcopenia or the loss of skeletal muscle is highly prevalent in many diseases, including short bowel syndrome (SBS). While adaptation is more likely in SBS patients with a colon-in-continuity, the co...
Detailed Description
Patients with short bowel syndrome (SBS) will be screened and included in longitudinal or cross-sectional studies if eligible. The longitudinal study will follow patients with type 1 SBS (enterostomy...
Eligibility Criteria
Inclusion
- Age ≥18 years old
- SBS diagnosis validated by small bowel length and either type 1 (enterostomy), type 2 or 3 (jejuno-colic or -ileal anastomosis)
- Patient not objecting to the collection of personal data as part of the study
Exclusion
- Pregnancy
- Remaining hail length unknown
- Patient expressing opposition to participating in the cohort
- Patients who are unable to express themselves
Key Trial Info
Start Date :
August 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05441345
Start Date
August 18 2022
End Date
July 16 2024
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Coprologie Fonctionnelle Hôpital Pitié-Salpêtrière
Paris, France, 75013